HighVista Strategies as of March 31, 2022
Portfolio Holdings for HighVista Strategies
HighVista Strategies holds 86 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dell Technologies CL C (DELL) | 11.3 | $18M | 355k | 50.19 | |
| Visa Com Cl A (V) | 5.8 | $9.1M | 41k | 221.76 | |
| Mastercard Incorporated Cl A (MA) | 5.5 | $8.6M | 24k | 357.38 | |
| Fiserv (FI) | 5.4 | $8.4M | 83k | 101.40 | |
| Paypal Holdings (PYPL) | 3.7 | $5.9M | 51k | 115.64 | |
| Msd Acquisition Corp Unit 03/25/2026 | 3.1 | $4.9M | 500k | 9.88 | |
| Coupang Cl A (CPNG) | 2.9 | $4.5M | 256k | 17.68 | |
| People's United Financial | 2.5 | $3.9M | 196k | 19.99 | |
| Fidelity National Information Services (FIS) | 2.4 | $3.8M | 38k | 100.41 | |
| Coherent | 2.4 | $3.7M | 14k | 273.31 | |
| Change Healthcare | 2.2 | $3.5M | 162k | 21.80 | |
| Cerner Corporation | 2.2 | $3.5M | 37k | 93.57 | |
| Activision Blizzard | 2.0 | $3.2M | 40k | 80.10 | |
| First Horizon National Corporation (FHN) | 2.0 | $3.2M | 135k | 23.49 | |
| Citrix Systems | 2.0 | $3.2M | 31k | 100.92 | |
| Aclaris Therapeutics (ACRS) | 1.7 | $2.7M | 158k | 17.24 | |
| Fate Therapeutics (FATE) | 1.6 | $2.5M | 65k | 38.77 | |
| Cytokinetics Com New (CYTK) | 1.5 | $2.4M | 66k | 36.81 | |
| Kura Oncology (KURA) | 1.5 | $2.4M | 148k | 16.08 | |
| Protagonist Therapeutics (PTGX) | 1.4 | $2.2M | 92k | 23.68 | |
| Relay Therapeutics (RLAY) | 1.3 | $2.1M | 69k | 29.92 | |
| Repare Therapeutics Ord (RPTX) | 1.3 | $2.0M | 143k | 14.24 | |
| Catalyst Partnrs Acquisitn C Unit 99/99/9999 | 1.3 | $2.0M | 200k | 10.10 | |
| Apellis Pharmaceuticals (APLS) | 1.2 | $1.9M | 37k | 50.82 | |
| Global Blood Therapeutics In | 1.1 | $1.8M | 51k | 34.65 | |
| Dyne Therapeutics (DYN) | 1.0 | $1.6M | 169k | 9.64 | |
| Arcus Biosciences Incorporated (RCUS) | 1.0 | $1.6M | 50k | 31.57 | |
| Amarin Corp Spons Adr New | 1.0 | $1.6M | 477k | 3.29 | |
| Biohaven Pharmaceutical Holding | 1.0 | $1.5M | 13k | 118.55 | |
| Novocure Ord Shs (NVCR) | 0.9 | $1.4M | 17k | 82.87 | |
| Chinook Therapeutics | 0.7 | $1.1M | 68k | 16.36 | |
| Invesco Db Commdy Indx Trck Unit (DBC) | 0.7 | $1.1M | 42k | 26.06 | |
| Amicus Therapeutics (FOLD) | 0.7 | $1.0M | 108k | 9.47 | |
| Avidity Biosciences Ord (RNA) | 0.6 | $982k | 53k | 18.47 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.6 | $979k | 3.8k | 260.93 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.6 | $971k | 44k | 21.96 | |
| Gh Research Ordinary Shares (GHRS) | 0.6 | $966k | 53k | 18.28 | |
| Argenx Se Sponsored Adr (ARGX) | 0.6 | $965k | 3.1k | 315.26 | |
| Generation Bio | 0.6 | $964k | 131k | 7.34 | |
| Dice Therapeutics | 0.6 | $937k | 49k | 19.14 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.6 | $918k | 7.8k | 117.38 | |
| Miragen Therapeutics (VRDN) | 0.6 | $907k | 49k | 18.49 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $907k | 5.6k | 163.28 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $906k | 54k | 16.65 | |
| Iveric Bio | 0.6 | $902k | 54k | 16.83 | |
| Sarepta Therapeutics (SRPT) | 0.6 | $884k | 11k | 78.16 | |
| Tricida | 0.6 | $881k | 107k | 8.22 | |
| Celldex Therapeutics Com New (CLDX) | 0.6 | $877k | 26k | 34.07 | |
| Keros Therapeutics (KROS) | 0.6 | $872k | 16k | 54.36 | |
| Horizon Therapeutics Pub L SHS | 0.6 | $869k | 8.3k | 105.26 | |
| Bridgebio Pharma (BBIO) | 0.6 | $866k | 85k | 10.15 | |
| Xenon Pharmaceuticals (XENE) | 0.5 | $856k | 28k | 30.58 | |
| C4 Therapeutics Com Stk (CCCC) | 0.5 | $843k | 35k | 24.25 | |
| Travere Therapeutics (TVTX) | 0.5 | $838k | 33k | 25.78 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $826k | 34k | 24.21 | |
| Galapagos Nv Spon Adr (GLPG) | 0.5 | $819k | 13k | 62.00 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $803k | 18k | 43.88 | |
| Merus N V (MRUS) | 0.5 | $803k | 30k | 26.42 | |
| Mirati Therapeutics | 0.5 | $802k | 9.8k | 82.23 | |
| Rocket Pharmaceuticals (RCKT) | 0.5 | $764k | 48k | 15.85 | |
| Iteos Therapeutics | 0.5 | $734k | 23k | 32.18 | |
| Ngm Biopharmaceuticals | 0.4 | $705k | 46k | 15.25 | |
| Cymabay Therapeutics | 0.4 | $645k | 207k | 3.11 | |
| Beam Therapeutics (BEAM) | 0.4 | $636k | 11k | 57.29 | |
| Gossamer Bio (GOSS) | 0.4 | $608k | 70k | 8.68 | |
| Invitae (NVTAQ) | 0.4 | $602k | 76k | 7.98 | |
| Edgewise Therapeutics (EWTX) | 0.4 | $579k | 60k | 9.69 | |
| Relmada Therapeutics (RLMD) | 0.4 | $577k | 21k | 26.99 | |
| Turning Point Therapeutics I | 0.4 | $565k | 21k | 26.86 | |
| Ideaya Biosciences (IDYA) | 0.4 | $554k | 50k | 11.19 | |
| Natera (NTRA) | 0.3 | $547k | 13k | 40.68 | |
| Biomea Fusion (BMEA) | 0.3 | $504k | 113k | 4.46 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $477k | 2.7k | 179.53 | |
| Prothena Corp SHS (PRTA) | 0.3 | $474k | 13k | 36.59 | |
| Bellus Health Com New | 0.3 | $448k | 65k | 6.87 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $444k | 4.5k | 98.12 | |
| Springworks Therapeutics (SWTX) | 0.3 | $438k | 7.8k | 56.48 | |
| Morphic Hldg (MORF) | 0.3 | $438k | 11k | 40.12 | |
| BioMarin Pharmaceutical (BMRN) | 0.3 | $431k | 5.6k | 77.06 | |
| I Mab Sponsored Ads (IMAB) | 0.3 | $413k | 25k | 16.26 | |
| Vistagen Therapeutics Com New | 0.2 | $392k | 316k | 1.24 | |
| Beigene Sponsored Adr (ONC) | 0.2 | $378k | 2.0k | 188.81 | |
| ImmunoGen | 0.2 | $370k | 78k | 4.76 | |
| Gritstone Oncology Ord (GRTSQ) | 0.2 | $364k | 88k | 4.12 | |
| Anaptysbio Inc Common (ANAB) | 0.2 | $346k | 14k | 24.72 | |
| Verve Therapeutics (VERV) | 0.2 | $321k | 14k | 22.81 |
